Evidence map›Paper›PMID 37239847›Full record

SynthesisInternational journal of molecular sciences2023

miRNAs, Mesenchymal Stromal Cells and Major Neoplastic and Inflammatory Skin Diseases: A Page Being Written: A Systematic Review.

Mariangela Di Vincenzo, Federico Diotallevi, Silvia Piccirillo, Gianluca Carnevale, Annamaria Offidani, Anna Campanati, Monia Orciani

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mariangela Di VincenzoDepartment of Clinical and Molecular Sciences-Histology, Università Politecnica delle Marche, 60126 Ancona, Italy.
Federico DiotalleviDepartment of Clinical and Molecular Sciences-Dermatological Clinic, Università Politecnica delle Marche, 60126 Ancona, Italy.ORCID 0000-0003-2274-1742
Silvia PiccirilloDepartment of Biomedical Sciences and Public Health-Pharmacology, Università Politecnica delle Marche, 60126 Ancona, Italy.
Gianluca CarnevaleDepartment of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplant, Oncology and Regenerative Medicine, Università di Modena e Reggio Emilia, 41121 Modena, Italy.ORCID 0000-0002-5348-5991
Annamaria OffidaniDepartment of Clinical and Molecular Sciences-Dermatological Clinic, Università Politecnica delle Marche, 60126 Ancona, Italy.
Anna CampanatiDepartment of Clinical and Molecular Sciences-Dermatological Clinic, Università Politecnica delle Marche, 60126 Ancona, Italy.ORCID 0000-0002-3740-0839
Monia OrcianiDepartment of Clinical and Molecular Sciences-Histology, Università Politecnica delle Marche, 60126 Ancona, Italy.ORCID 0000-0003-4503-3693
Marche Polytechnic University · ITUniversity of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Micro RNAs (miRNAs) are a type of non-coding RNA (ncRNA) and typically interact with specific target mRNAs through complementary base pairing, affecting their translation and/or stability. MiRNAs regulate nearly all cellular functions, including the cell fate of mesenchymal stromal cells (MSCs). It is now accepted that various pathologies arise at the stem level, and, in this scenario, the role played by miRNAs in the fate of MSCs becomes of primary concern. Here we have considered the existing literature in the field of miRNAs, MSCs and skin diseases, classified as inflammatory (such as psoriasis and atopic dermatitis-AD) and neoplastic (melanoma and non-melanoma-skin-cancer including squamous cell and basal cell carcinoma) diseases. In this scoping review article, the evidence recovered indicates that this topic has attracted attention, but it is still a matter of opinion. A protocol for this review was registered in PROSPERO with the registration number "CRD42023420245". According to the different skin disorders and to the specific cellular mechanisms considered (cancer stem cells, extracellular vesicles, inflammation), miRNAs may play a pro- or anti-inflammatory, as well as a tumor suppressive, or supporting, role, indicating a complex regulation of their function. It is evident that the mode of action of miRNAs is more than a switch on-off, and all the observed effects of their dysregulated expression must be checked in a detailed analysis of the targeted proteins. The involvement of miRNAs has been studied mainly for squamous cell carcinoma and melanoma, and much less in psoriasis and AD; different mechanisms have been considered, such as miRNAs included in extracellular vesicles derived both from MSCs or tumor cells, miRNAs involved in cancer stem cells formation, up to miRNAs as candidates to be new therapeutic tools.

Indexed as

Mesenchymal Stem CellsMicroRNAsNeoplasmsPsoriasisSkin DiseasesCell DifferentiationHumansMicroRNAshuman mesenchymal stromal cellsmiRNAsskin disorders

Identifiers

PMID37239847
PMCPMC10217999
OpenAlexW4378516466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.